Literature DB >> 2489045

Molecular requirements for immunoglobulin heavy chain constant region gene switch-recombination revealed with switch-substrate retroviruses.

D E Ott1, K B Marcu.   

Abstract

We have employed a retroviral vector, ZN(Smu/S gamma 2b)tk1, as a means of introducing immunoglobulin heavy chain (IgH) switch (S) region sequences into B cell lines to directly measure their switch-recombinase activities. In an earlier study, we demonstrated that retrovector Smu-S gamma 2b recombination events occurred in two thymidine kinase (tk)-negative murine pre-B cell lines (18-8 and 38B9) upon selection in bromodeoxyuridine (BUdR) media for the loss of an Htk gene inserted in between the vector's Smu and S gamma 2b sequences. Here we have used this assay system to show that the 300-18 murine pre-B cell line possesses a very high level of switch-recombinase activity (greater than 1 event in 2500 cells/generation) while a terminally differentiated, antibody-secreting hybridoma line (A39R 1.1) has no detectable recombinase activity. Both S mu and S gamma 2b segments are required for switch region-mediated deletions. Retrovectors harboring only an Smu segment or an Smu segment and a portion of the murine c-myc gene in place of S gamma 2b sequences were both non-recombinagenic in this assay system. Nucleotide sequence analysis of six retrovector S segment recombinants, recovered from ZN(Smu/S gamma 2b) tk1-infected 18-8 and 39B9 pre-B lines, did not reveal homology at their sites of recombination. We conclude that: (1) S segment repetitive sequences play an essential but indirect role in IgCH gene switch-recombination, which occurs by an illegitimate, non-homologous mechanism; (2) the c-myc gene is not a significant target for switch-recombination; and (3) since endogenous Smu and S gamma 2b rearrangements were not observed in populations and clones of pre-B cells expressing a high level of switch-recombinase activity, multiple factors (presumably contributed in part by the degree of S segment accessibility) in addition to S recombinase activity are required for CH class switching.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2489045     DOI: 10.1093/intimm/1.6.582

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  8 in total

1.  An element in the endogenous IgH locus stimulates gene targeting in hybridoma cells.

Authors:  A Buzina; M J Shulman
Journal:  Nucleic Acids Res       Date:  1996-04-15       Impact factor: 16.971

Review 2.  DNA sequences at immunoglobulin switch region recombination sites.

Authors:  W Dunnick; G Z Hertz; L Scappino; C Gritzmacher
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

3.  Synergistic antitumor activity of low-dose c-Met tyrosine kinase inhibitor and sorafenib on human non-small cell lung cancer cells.

Authors:  Ling Fu; Liang Guo; Yi Zheng; Zhenyu Zhu; Mingyue Zhang; Xiaohua Zhao; Hongxue Cui
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

Review 4.  Current insights into the mechanism of mammalian immunoglobulin class switch recombination.

Authors:  Kefei Yu; Michael R Lieber
Journal:  Crit Rev Biochem Mol Biol       Date:  2019-09-11       Impact factor: 8.250

5.  Interchromosomal recombination is suppressed in mammalian somatic cells.

Authors:  M J Shulman; C Collins; A Connor; L R Read; M D Baker
Journal:  EMBO J       Date:  1995-08-15       Impact factor: 11.598

6.  Evidence for class-specific factors in immunoglobulin isotype switching.

Authors:  A Shanmugam; M J Shi; L Yauch; J Stavnezer; A L Kenter
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

Review 7.  AID to overcome the limitations of genomic information by introducing somatic DNA alterations.

Authors:  Tasuku Honjo; Masamichi Muramatsu; Hitoshi Nagaoka; Kazuo Kinoshita; Reiko Shinkura
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2006-05       Impact factor: 3.493

8.  Processing of switch transcripts is required for targeting of antibody class switch recombination.

Authors:  K Hein; M G Lorenz; G Siebenkotten; K Petry; R Christine; A Radbruch
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.